Anakinra and tocilizumab in the chronic phase of febrile infection-related epilepsy syndrome (FIRES): Effectiveness and safety from a case-series-Reference-Cited by-同舟云学术

Anakinra and tocilizumab in the chronic phase of febrile infection-related epilepsy syndrome (FIRES): Effectiveness and safety from a case-series

Published:2022-08 Issue: Volume:100 Page:51-55
ISSN:1059-1311
Container-title:Seizure
language:en
Short-container-title:Seizure

Author:

Aledo-Serrano Angel^ORCID,Hariramani Roshan,Gonzalez-Martinez Alicia^ORCID,Álvarez-Troncoso Jorge^ORCID,Toledano Rafael,Bayat Allan^ORCID,Garcia-Morales Irene,Becerra Juan Luis,Villegas-Martínez Irene^ORCID,Beltran-Corbellini Alvaro,Gil-Nagel Antonio

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference25 articles.

1. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions;Hirsch;Epilepsia,2018

2. The spectrum of neuroimaging findings in febrile infection-related epilepsy syndrome (FIRES): a literature review;Culleton;Epilepsia,2019

3. Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children;Kramer;Epilepsia,2011

4. Febrile Infection-Related Epilepsy Syndrome (FIRES): a Literature Review and Case Study;Fox;Neurodiagnostic J,2017

5. New-onset refractory status epilepticus;Gaspard;Neurology,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TRPV1 channel in the pathophysiology of epilepsy and its potential as a molecular target for the development of new antiseizure drug candidates;Progress in Neurobiology;2024-09

2. Mitochondrial dysfunction in chronic neuroinflammatory diseases (Review);International Journal of Molecular Medicine;2024-04-02

3. Second‐line immunotherapy in new onset refractory status epilepticus;Epilepsia;2024-03-02

4. Status epilepticus: what's new for the intensivist;Current Opinion in Critical Care;2024-02-13

5. Interleukins in Epilepsy: Friend or Foe;Neuroscience Bulletin;2024-01-24